Rising Cancer Prevalence Drives Growth In Single-Cell Genome Sequencing Market: Key Factor Driving The Growth In The Single-Cell Genome Sequencing Market

The Single-Cell Genome Sequencing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Single-Cell Genome Sequencing Market Size During the Forecast Period?
There has been a swift expansion in the single-cell genome sequencing market size over the past few years. The market is projected to increase from $2.49 billion in 2024 to $2.84 billion in 2025 with a compound annual growth rate (CAGR) of 13.9%. Factors such as enhanced comprehension of genetic diversity, growing demand for precision medicine, escalated cancer research, rise in infectious diseases, and augmented healthcare spending have contributed to the growth in this period.

The market size of single-cell genome sequencing is predicted to undergo swift expansion in the forthcoming years, reaching $5.04 billion in 2029 with a 15.4% compound annual growth rate (CAGR). The expected growth during the projection period is due to the rising cases of autoimmune diseases and growing neurological disorders, along with increased government efforts and funding, the emergence of contract research organizations, and growing recognition of the potential of scrna-seq. The forecast period is likely to witness key trends like upgrades in single-cell sequencing technologies, the emergence of single-cell multi-omics technologies, cooperative efforts for faster advancements, novel solutions, and strategic alliances among key market players.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12655

What Are the High-Growth Segments in the Single-Cell Genome Sequencing Market?
The single-cell genome sequencing market covered in this report is segmented -

1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

Subsegments:
1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems
2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

What Key Drivers Are Expected to Influence Future Single-Cell Genome Sequencing Market Growth?
The single-cell genome sequencing market's growth is predicted to be boosted by the increasing incidence of cancer. Cancer encompasses a wide range of ailments characterized by irregular cell growth and unchecked cell division, due to alterations in the genes that maintain normal cell function and govern cell division. The genetic mutations unique to cancer are something single-cell genome sequencing can bring to light by examining individual cancer cells. To illustrate, the American Cancer Society, a U.S. cancer-fighting group, documented approximately 1.9 million new cases of cancer, and 609,360 cancer-related deaths in the year 2022 alone. Moreover, by 2040, it's predicted that there will be around 27.5 million new instances of cancer, and 16.3 million cancer fatalities. As a result, the escalating instances of cancer are anticipated to drive growth in the single-cell genome sequencing market.

Which Companies Hold the Largest Share Across Different Single-Cell Genome Sequencing Market Segments?
Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

What Trends Are Driving Growth in The Single-Cell Genome Sequencing Market?
The emergence of new technologies is an influential trend observed in the single-cell genome sequencing market. Leading companies in the market are strategizing to fortify their position by developing state-of-the-art solutions. For example, in May 2023, Mission Bio Inc. a company based in the US and specializing in single-cell multi-omics platform for cancer research and biomarker development, rolled out the Tapestri Genome Editing Solution. This latest product offers a comprehensive approach to genome editing analysis. The innovative method is expected to prove highly effective as an analytical tool in generating next-generation gene-edited drugs, as it provides single-cell insights that could impact efficacy and safety.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

What Are the Emerging Geographies for The Single-Cell Genome Sequencing Market Growth?
North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Single-Cell Genome Sequencing Market?
2. What is the CAGR expected in the Single-Cell Genome Sequencing Market?
3. What Are the Key Innovations Transforming the Single-Cell Genome Sequencing Industry?
4. Which Region Is Leading the Single-Cell Genome Sequencing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.